🔬 What is Mounjaro?
Mounjaro (generic name: tirzepatide) is a prescription injectable medication manufactured by Eli Lilly. It is approved by the U.S. Food and Drug Administration (FDA) for:
Type 2 Diabetes Management: Used alongside diet and exercise to improve glycemic control.
Weight Management (off-label use or under additional indications): Currently under evaluation or prescribed off-label in some contexts for obesity or weight-related conditions.
Key Details:
Drug Class: Dual GIP and GLP-1 receptor agonist
Route: Subcutaneous injection (pre-filled single-use pen)
DEA Schedule: Not a controlled substance (non-scheduled)
RCRA Status: Typically non-hazardous pharmaceutical waste
♻️ How Should Mounjaro Be Disposed Of?
Even though Mounjaro is not a controlled substance or a RCRA hazardous waste, it is still considered pharmaceutical waste. It must be disposed of adequately to protect health, safety, and the environment.
Regulatory Considerations:
EPA: While not hazardous under RCRA, disposal must comply with pharmaceutical waste regulations, especially state-specific rules (e.g., California, Washington, and Massachusetts may have stricter standards).
DOT: If transported, empty or partially used pens may be considered regulated medical waste (sharps).
OSHA: Requires safe handling of sharps to avoid needle-stick injuries (1910.1030).
USPS (if mailed): Must be packaged according to UN3291 for regulated medical waste mail-back programs.
🛠️ PureWay Disposal Solutions for Mounjaro
PureWay offers a comprehensive suite of services and products that fully support compliant, safe, and convenient disposal of Mounjaro by healthcare providers, pharmacies, or individuals.
1. Sharps Mail-Back Systems (UN3291 Compliant)
Suitable for the disposal of used or unused Mounjaro pens.
Includes pre-labeled, pre-paid containers approved by the USPS for regulated medical waste.
Ensures full compliance with DOT, USPS, and OSHA requirements.
Standard sizes: 1-quart, 2-gallon, 3-gallon containers.